| Citation Matrix | Glossary HistCite Guide |
Nodes: 129,
Authors: 553,
Sources: 71,
Outer References: 4441
Collection span: 2002 - 2004
LCSb: 30 (23.26%) nodes before 2003
(1 years)
LCSe: 99 (76.74%) nodes after 2002
(2 years)
View: Bibliometric. Sorted by year, source, volume, issue, page.
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 57 | 1 2002 ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37 37():225-236
McLaughlin F; LaThangue N Tumor classification for tailored cancer therapy | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 2 | 1 | 107 | 2 2002 BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY 15(4):597-621
Kebriaei P; Anastasi J; Larson RA Acute lymphoblastic leukaemia: diagnosis and classification | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 3 | 1 | 113 | 3 2002 BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY 15(4):771-790
Thomas DA; Cortes J; Kantarjian HM New agents in the treatment of acute lymphocytic leukaemia | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 4 | 1 | 8 | 4 2002 CANCER CELL 1(2):109-110
Staudt LM It's ALL in the diagnosis | 4 | 1.33 | 5 | 1.67 | 2 | 2 |
| 5 | 0 | 25 | 5 2002 CANCER CELL 1(2):133-143
Yeoh EJ; Ross ME; Shurtleff SA; Williams WK; Patel D; Mahfouz R; Behm FG; Raimondi SC; Relling MV; Patel A; Cheng C; Campana D; Wilkins D; Zhou XD; Li JY; Liu HQ; Pui CH; Evans WE; Naeve C; Wong LS; Downing JR Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling | 128 | 42.67 | 128 | 42.67 | 29 | 99 |
| 6 | 1 | 33 | 6 2002 CANCER CELL 1(5):417-420
Gilliland DG; Tallman MS Focus on acute leukemias | 2 | 0.67 | 6 | 2.00 | 1 | 1 |
| 7 | 1 | 20 | 7 2002 CANCER CELL 2(2):99-102
Shannon KM Resistance in the land of molecular cancer therapeutics | 1 | 0.33 | 3 | 1.00 | 0 | 1 |
| 8 | 1 | 36 | 8 2002 CANCER CELL 2(5):353-361
Miller LD; Long PM; Wong L; Mukherjee S; McShane LM; Liu ET Optimal gene expression analysis by microarrays | 1 | 0.33 | 9 | 3.00 | 0 | 1 |
| 9 | 2 | 94 | 9 2002 CANCER CELL 2(6):437-445
Downing JR; Shannon KM Acute leukemia: A pediatric perspective | 2 | 0.67 | 5 | 1.67 | 0 | 2 |
| 10 | 1 | 51 | 10 2002 CLINICAL CANCER RESEARCH 8(10):3118-3130
Moos PJ; Raetz EA; Carlson MA; Szabo A; Smith FE; Willman C; Wei Q; Hunger SP; Carroll WL Identification of gene expression profiles that segregate patients with childhood leukemia | 3 | 1.00 | 5 | 1.67 | 0 | 3 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 11 | 1 | 43 | 11 2002 CURRENT OPINION IN HEMATOLOGY 9(4):339-344
Armstrong SA; Hsieh JJD; Korsmeyer SJ Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias | 1 | 0.33 | 1 | 0.33 | 0 | 1 |
| 12 | 1 | 36 | 12 2002 CURRENT OPINION IN PHARMACOLOGY 2(5):551-554
Crowther DJ Applications of microarrays in the pharmaceutical industry | 0 | 0.00 | 1 | 0.33 | 0 | 0 |
| 13 | 1 | 28 | 13 2002 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 127(42):2216-2222
Kohlmann A; Schoch C; Schnittger S; Kern W; Haferlach T Diagnosis of leukemia using microarray technology | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 14 | 1 | 6 | 14 2002 EUROPEAN JOURNAL OF CANCER 38(17):2207-2209
Hayward RL; Smyth JF A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 15 | 1 | 54 | 15 2002 FRONTIERS IN BIOSCIENCE 7():C74-C82
Hunter SB; Moreno CS Expression microarray analysis of brain tumors: What have we learned so far | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 16 | 1 | 52 | 16 2002 HUMAN MOLECULAR GENETICS 11(26):3283-3298
Campanaro S; Romualdi C; Fanin M; Celegato B; Pacchioni B; Trevisan S; Laveder P; De Pitta C; Pegoraro E; Hayashi YK; Valle G; Angelini C; Lanfranchi G Gene expression profiling in dysferlinopathies using a dedicated muscle microarray | 0 | 0.00 | 5 | 1.67 | 0 | 0 |
| 17 | 1 | 48 | 17 2002 INTERNATIONAL JOURNAL OF HEMATOLOGY 76():59-64
Shaughnessy JD; Barlogie B Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myeloma | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 18 | 1 | 57 | 18 2002 LEUKEMIA 16(11):2213-2221
Niini T; Vettenranta K; Hollmen J; Larramendy ML; Aalto Y; Wikman H; Nagy B; Seppanen JK; Salvador AF; Mannila H; Saarinen-Pihkala UM; Knuutila S Expression of myeloid-specific genes in childhood acute lymphoblastic leukemia - a cDNA array study | 0 | 0.00 | 1 | 0.33 | 0 | 0 |
| 19 | 1 | 29 | 19 2002 MOLECULAR CANCER THERAPEUTICS 1(10):769-776
Huang KC; Rao PH; Lau CC; Heard E; Ng SK; Brown C; Mok SC; Berkowitz RS; Ng SW Relationship of XIST expression and responses of ovarian cancer to chemotherapy | 0 | 0.00 | 2 | 0.67 | 0 | 0 |
| 20 | 1 | 53 | 20 2002 MOLECULAR CELL 10(5):1107-1117
Milne TA; Briggs SD; Brock HW; Martin ME; Gibbs D; Allis CD; Hess JL MLL targets SET domain methyltransferase activity to Hox gene promoters | 9 | 3.00 | 35 | 11.67 | 0 | 9 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 21 | 2 | 19 | 21 2002 MONATSSCHRIFT KINDERHEILKUNDE 150(8):924-+
Seeger K; Eckert C; Kirschner R; Henze G; Hernaiz-Driever P Paediatric oncology. Molecular oncology in infants | 0 | 0.00 | 1 | 0.33 | 0 | 0 |
| 22 | 1 | 50 | 22 2002 NATURE GENETICS 32():533-540
Chung CH; Bernard PS; Perou CM Molecular portraits and the family tree of cancer | 1 | 0.33 | 22 | 7.33 | 0 | 1 |
| 23 | 1 | 2 | 23 2002 NATURE REVIEWS CANCER 2(4):248-248
Novak K Predicting outcome | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 24 | 1 | 7 | 24 2002 NEUROLOGY 59(8):1128-1129
Thornton CA; Welle SL Molecular fingerprints of inflammatory myopathies | 0 | 0.00 | 2 | 0.67 | 0 | 0 |
| 25 | 1 | 30 | 25 2002 PHARMACEUTICAL RESEARCH 19(12):1773-1778
Chin KV; Kong ANT Application of DNA Microarrays in pharmacogenomics and toxicogenomics | 0 | 0.00 | 2 | 0.67 | 0 | 0 |
| 26 | 2 | 78 | 26 2002 PHARMACOGENOMICS 3(5):589-601
Chicurel ME; Dalma-Weiszhausz DD Microarrays in pharmacogenomics - advances and future promise | 0 | 0.00 | 6 | 2.00 | 0 | 0 |
| 27 | 1 | 29 | 27 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(15):10014-10019
Muschen M; Lee S; Zhou GL; Feldhahn N; Barath VS; Chen JJ; Moers C; Kronke M; Rowley JD; Wang SM Molecular portraits of B cell lineage commitment | 0 | 0.00 | 9 | 3.00 | 0 | 0 |
| 28 | 1 | 37 | 28 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(23):14925-14930
Qian ZJ; Fernald AA; Godley LA; Larson RA; Le Beau MM Expression profiling of CD34(+) hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia | 3 | 1.00 | 5 | 1.67 | 0 | 3 |
| 29 | 1 | 51 | 29 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(23):15101-15106
Wiemels JL; Leonard BC; Wang YX; Segal MR; Hunger SP; Smith MT; Crouse V; Ma XM; Buffler PA; Pine SR Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia | 0 | 0.00 | 5 | 1.67 | 0 | 0 |
| 30 | 1 | 72 | 30 2002 TRENDS IN MOLECULAR MEDICINE 8(9):436-442
Collins EC; Rabbitts TH The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism | 1 | 0.33 | 4 | 1.33 | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 31 | 2 | 17 | 31 2003 ADVANCES IN ANATOMIC PATHOLOGY 10(6):338-346
Master SR; Mies C Gene-expression profiles and breast-cancer prognosis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 32 | 2 | 17 | 32 2003 ADVANCES IN WEB-AGE INFORMATION MANAGEMENT, PROCEEDINGS 2762():254-265
Li JY; Wong LS Using rules to analyse bio-medical data: A comparison between c4.5 and PCL | 0 | 0.00 | 0 | 0.00 | 0 | |
| 33 | 1 | 44 | 33 2003 AMERICAN JOURNAL OF PATHOLOGY 162(3):925-932
Higgins JPT; Shinghal R; Gill H; Reese JH; Terris M; Cohen RJ; Fero M; Pollack JR; van de Rijn M; Brooks JD Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray | 0 | 0.00 | 2 | 1.00 | 0 | |
| 34 | 1 | 25 | 34 2003 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 29(3):S32-S36
Kaminski N Microarray analysis of idiopathic pulmonary fibrosis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 35 | 1 | 13 | 35 2003 AMERICAN JOURNAL OF SURGICAL PATHOLOGY 27(3):414-415
Ladanyi M Translocation-based molecular diagnosis of sarcomas | 0 | 0.00 | 0 | 0.00 | 0 | |
| 36 | 1 | 16 | 36 2003 ANNALES DE BIOLOGIE CLINIQUE 61(5):513-519
Benattar L; Flandrin G Classification of mature B-cell neoplasms | 0 | 0.00 | 0 | 0.00 | 0 | |
| 37 | 1 | 51 | 37 2003 ANNALS OF HEMATOLOGY 82(6):323-332
Schwaenen C; Wessendorf S; Kestler HA; Dohner H; Lichter P; Bentz M DNA microarray analysis in malignant lymphomas | 0 | 0.00 | 1 | 0.50 | 0 | |
| 38 | 1 | 65 | 38 2003 ARTIFICIAL INTELLIGENCE REVIEW 20(1-2):75-93
Stetter M; Deco G; Dejori M Large-scale computational modeling of genetic regulatory networks | 0 | 0.00 | 0 | 0.00 | 0 | |
| 39 | 1 | 88 | 39 2003 BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 1603(2):99-111
Watters JW; McLeod HL Cancer pharmacogenomics: current and future applications | 0 | 0.00 | 3 | 1.50 | 0 | |
| 40 | 1 | 14 | 40 2003 BIOINFORMATICS 19(1):71-78
Li JY; Liu HQ; Downing JR; Yeoh AEJ; Wong LS Simple rules underlying gene expression profiles of more than six subtypes of acute lymphoblastic leukemia (ALL) patients | 2 | 1.00 | 5 | 2.50 | 2 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 41 | 1 | 16 | 41 2003 BIOINFORMATICS 19(9):1124-1131
Nakahara H; Nishimura S; Inoue M; Hori G; Amari S Gene interaction in DNA microarray data is decomposed by information geometric measure | 0 | 0.00 | 0 | 0.00 | 0 | |
| 42 | 1 | 22 | 42 2003 BIOINFORMATICS 19(13):1620-1627
Pavlidis P; Li QH; Noble WS The effect of replication on gene expression microarray experiments | 0 | 0.00 | 0 | 0.00 | 0 | |
| 43 | 1 | 101 | 43 2003 BIOTECHNIQUES ():4-+
Ochs ME; Godwin AK Microarrays in cancer: Research and applications | 0 | 0.00 | 0 | 0.00 | 0 | |
| 44 | 1 | 35 | 44 2003 BIOTECHNIQUES ():22-+
Scharpf R; Garrett ES; Hu J; Parmigiani G Statistical modeling and visualization of molecular profiles in cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 45 | 2 | 60 | 45 2003 BIOTECHNIQUES ():64-+
O'Neill GM; Catchpoole DR; Golemis EA From correlation to causality: Microarrays, cancer, and cancer treatment | 0 | 0.00 | 0 | 0.00 | 0 | |
| 46 | 1 | 53 | 46 2003 BLOOD 101(3):1128-1140
Zhan FH; Tian EM; Bumm K; Smith R; Barlogie B; Shaughnessy J Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development | 4 | 2.00 | 11 | 5.50 | 4 | |
| 47 | 2 | 52 | 47 2003 BLOOD 102(1):262-268
Ferrando AA; Armstrong SA; Neuberg DS; Sallan SE; Silverman LB; Korsmeyer SJ; Look AT Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation | 7 | 3.50 | 10 | 5.00 | 7 | |
| 48 | 3 | 37 | 48 2003 BLOOD 102(5):1849-1856
Yagi T; Morimoto A; Eguchi M; Hibi S; Sako M; Ishii E; Mizutani S; Imashuku S; Ohki M; Ichikawa H Identification of a gene expression signature associated with pediatric AML prognosis | 4 | 2.00 | 4 | 2.00 | 4 | |
| 49 | 1 | 46 | 49 2003 BLOOD 102(7):2395-2402
Schoch C; Schnittger S; Klaus M; Kern W; Hiddemann W; Haferlach T AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases | 0 | 0.00 | 1 | 0.50 | 0 | |
| 50 | 1 | 42 | 50 2003 BLOOD 102(7):2562-2567
Fonseca R; Debes-Marun CS; Picken EB; Dewald GW; Bryant SC; Winkler JM; Blood E; Oken MM; Santana-Davila R; Gonzalez-Paz N; Kyle RA; Gertz MA; Dispenzieri A; Lacy MQ; Greipp PR The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 51 | 4 | 38 | 51 2003 BLOOD 102(8):2951-2959
Ross ME; Zhou XD; Song GC; Shurtleff SA; Girtman K; Williams WK; Liu HC; Mahfouz R; Raimondi SC; Lenny N; Patel A; Downing JR Classification of pediatric acute lymphoblastic leukemia by gene expression profiling | 1 | 0.50 | 1 | 0.50 | 1 | |
| 52 | 1 | 41 | 52 2003 BLOOD 102(8):3010-3015
Paulsson K; Panagopoulos I; Knuutila S; Jee KJ; Garwicz S; Fioretos T; Mitelman F; Johansson B Formation of trisomies and their parental origin in hyperdiploid childhood acute lymphoblastic leukemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| 53 | 1 | 38 | 53 2003 BRITISH JOURNAL OF HAEMATOLOGY 120(4):549-555
Simone JV A history of St Jude Children's Research Hospital | 0 | 0.00 | 0 | 0.00 | 0 | |
| 54 | 2 | 200 | 54 2003 CANCER 98(7):1337-1354
Faderl S; Jeha S; Kantarjian HM The biology and therapy of adult acute lymphoblastic leukemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| 55 | 1 | 37 | 55 2003 CANCER CELL 3(2):161-171
So CW; Karsunky H; Passegue E; Cozzio A; Weissman IL; Cleary ML MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice | 3 | 1.50 | 8 | 4.00 | 3 | |
| 56 | 1 | 50 | 56 2003 CANCER CELL 3(2):173-183
Armstrong SA; Kung AL; Mabon ME; Silverman LB; Stam RW; Den Boer ML; Pieters R; Kersey JH; Sallan SE; Fletcher JA; Golub TR; Griffin JD; Korsmeyer SJ Inhibition of FLT3 in MLL: Validation of a therapeutic target identified by gene expression based classification | 7 | 3.50 | 19 | 9.50 | 7 | |
| 57 | 4 | 14 | 57 2003 CANCER CELL 4(2):81-83
Hsu K; Look AT Turning on a dimer: New insights into MLL chimeras | 0 | 0.00 | 0 | 0.00 | 0 | |
| 58 | 2 | 62 | 58 2003 CANCER CELL 4(3):197-207
Martin ME; Milne TA; Bloyer S; Galoian K; Shen WP; Gibbs D; Brock HW; Slany R; Hess JL Dimerization of MLL fusion proteins immortalizes hematopoietic cells | 0 | 0.00 | 1 | 0.50 | 0 | |
| 59 | 1 | 43 | 59 2003 CANCER RESEARCH 63(5):1046-1053
Kuo ML; Duncavage EJ; Mathew R; den Besten W; Pei DQ; Naeve D; Yamamoto T; Cheng C; Sherr CJ; Roussel MF Arf induces p53-dependent and -independent antiproliferative genes | 0 | 0.00 | 4 | 2.00 | 0 | |
| 60 | 1 | 46 | 60 2003 CANCER RESEARCH 63(16):4882-4887
Tsutsumi S; Taketani T; Nishimura K; Ge XJ; Taki T; Sugita K; Ishii E; Hanada R; Ohki M; Aburatani H; Hayashi Y Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements | 2 | 1.00 | 2 | 1.00 | 2 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 61 | 1 | 77 | 61 2003 CANCER RESEARCH 63(17):5428-5437
Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ A molecular fingerprint for medulloblastoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 62 | 1 | 58 | 62 2003 CANCER TREATMENT REVIEWS 29(1):3-10
Popat U; Carrum G; Heslop HE Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| 63 | 1 | 166 | 63 2003 CANCER TREATMENT REVIEWS 29(1):31-44
Rubnitz JE; Pui CH Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| 64 | 3 | 9 | 64 2003 CELL 115(3):248-250
Gilliland DG Proteolytic processing in development and leukemogenesis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 65 | 4 | 49 | 65 2003 CELL 115(3):293-303
Hsieh JJD; Cheng EHY; Korsmeyer SJ Taspase1: A threonine aspartase required for cleavage of MLL and proper HOX gene expression | 0 | 0.00 | 0 | 0.00 | 0 | |
| 66 | 1 | 61 | 66 2003 CLINICAL AND LABORATORY HAEMATOLOGY 25(4):209-220
Levene AP; Morgan GJ; Davies FE The use of genetic microarray analysis to classify and predict prognosis in haematological malignancies | 0 | 0.00 | 0 | 0.00 | 0 | |
| 67 | 1 | 28 | 67 2003 CLINICAL CANCER RESEARCH 9(15):5486-5492
Wong YF; Selvanayagam ZE; Wei N; Porter J; Vittal R; Hu R; Lin Y; Liao J; Shih JW; Cheung TH; Lo KWK; Yim SF; Yip SK; Ngong DT; Siu N; Chan LKY; Chan CS; Kong T; Kutlina E; McKinnon RD; Denhardt DT; Chin KV; Chung TKH Expression Genomics of cervical cancer: Molecular classification and prediction of radiotherapy response by DNA microarray | 0 | 0.00 | 0 | 0.00 | 0 | |
| 68 | 3 | 37 | 68 2003 CURRENT OPINION IN GENETICS & DEVELOPMENT 13(1):97-103
Liu ET Classification of cancers by expression profiling | 1 | 0.50 | 2 | 1.00 | 1 | |
| 69 | 1 | 83 | 69 2003 CURRENT OPINION IN HEMATOLOGY 10(4):290-296
Silverman LB; Sallan SE Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatment | 0 | 0.00 | 1 | 0.50 | 0 | |
| 70 | 1 | 149 | 70 2003 CURRENT OPINION IN ONCOLOGY 15(1):23-35
Ravindranath Y Recent advances in pediatric acute lymphoblastic and myeloid leukemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 71 | 1 | 22 | 71 2003 CYTOMETRY PART B-CLINICAL CYTOMETRY 55B(1):29-36
Kern W; Kohlmann A; Wuchter C; Schnittger S; Schoch C; Mergenthaler S; Ratei R; Ludwig WD; Hiddemann W; Haferlach T Correlation of protein expression and gene expression in acute leukemia | 0 | 0.00 | 2 | 1.00 | 0 | |
| 72 | 1 | 43 | 72 2003 DATABASE THEORY ICDT 2003, PROCEEDINGS 2572():31-46
Li JY; Ng SK; Wong LS Bioinformatics adventures in database research | 0 | 0.00 | 0 | 0.00 | 0 | |
| 73 | 1 | 30 | 73 2003 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 128(39):2030-2036
Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels R Gene expression analysis in sarcoma using microarray technology | 0 | 0.00 | 0 | 0.00 | 0 | |
| 74 | 1 | 42 | 74 2003 DRUG DISCOVERY TODAY 8(1):31-38
Nicolette CA; Miller GA The identification of clinically relevant markers and therapeutic targets | 0 | 0.00 | 3 | 1.50 | 0 | |
| 75 | 1 | 123 | 75 2003 GASTROENTEROLOGY 124(2):521-536
Bonen DK; Cho JH The genetics of inflammatory bowel disease | 0 | 0.00 | 12 | 6.00 | 0 | |
| 76 | 3 | 49 | 76 2003 GENES & DEVELOPMENT 17(18):2298-2307
Ayton PM; Cleary ML Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9 | 2 | 1.00 | 3 | 1.50 | 2 | |
| 77 | 1 | 29 | 77 2003 GENES CHROMOSOMES & CANCER 37(2):149-158
Debernardi S; Lillington DM; Chaplin T; Tomlinson S; Amess J; Rohatiner A; Lister TA; Young BD Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events | 3 | 1.50 | 3 | 1.50 | 3 | |
| 78 | 1 | 25 | 78 2003 GENES CHROMOSOMES & CANCER 37(4):396-405
Kohlmann A; Schoch C; Schnittger S; Dugas M; Hiddemann W; Kern W; Haferlach T Molecular characterization of acute leukemias by use of microarray technology | 3 | 1.50 | 4 | 2.00 | 3 | |
| 79 | 1 | 46 | 79 2003 HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 17(2):377-+
Mariadason JM; Augenlicht LH; Arango D Microarray analysis in the clinical management of cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 80 | 2 | 198 | 80 2003 IMMUNOLOGICAL REVIEWS 194(1):140-163
Shaughnessy JD; Barlogie B Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling | 0 | 0.00 | 1 | 0.50 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 81 | 1 | 55 | 81 2003 INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 41(6):231-240
Muller M Pharmacogenomics and drug response | 0 | 0.00 | 0 | 0.00 | 0 | |
| 82 | 2 | 94 | 82 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 77(3):213-225
Shaughnessy JD Global gene expression profiling in the study of multiple myeloma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 83 | 1 | 62 | 83 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 78(5):383-389
Pui CH; Ribeiro RC International collaboration on childhood leukemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| 84 | 11 | 125 | 84 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 78(5):390-401
Eguchi M; Eguchi-Ishimae M; Greaves M The role of the MLL gene in infant leukemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| 85 | 6 | 186 | 85 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 78(5):402-413
Pieters R; den Boer ML Molecular pharmacodynamics in childhood leukemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| 86 | 10 | 36 | 86 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 78(5):414-420
Hayashi Y Gene expression profiling in childhood acute leukemia: Progress and perspectives | 0 | 0.00 | 0 | 0.00 | 0 | |
| 87 | 1 | 12 | 87 2003 JOURNAL OF CLINICAL ONCOLOGY 21(5):760-761
Schiffer CA Differences in outcome in adolescents with acute lymphoblastic leukemia: A consequence of better regimens? better doctors? both? | 0 | 0.00 | 1 | 0.50 | 0 | |
| 88 | 1 | 38 | 88 2003 JOURNAL OF CLINICAL ONCOLOGY 21(17):3262-3268
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Korholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJL; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJP; Janka-Schaub GE Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia | 1 | 0.50 | 1 | 0.50 | 1 | |
| 89 | 1 | 33 | 89 2003 JOURNAL OF CLINICAL PATHOLOGY 56(4):249-253
Moppett J; Burke GAA; Steward CG; Oakhill A; Goulden NJ The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia | 0 | 0.00 | 1 | 0.50 | 0 | |
| 90 | 1 | 83 | 90 2003 JOURNAL OF MOLECULAR DIAGNOSTICS 5(2):63-72
Nashed AL; Rao KW; Gulley ML Clinical applications of BCR-ABL molecular testing in acute leukemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 91 | 1 | 31 | 91 2003 KLINISCHE PADIATRIE 215(3):135-138
Staege MS; Hattenhorst UE; Neumann I; Hutter C; Foja S; Burdach S DNA-microarrays as tools for the Identification of tumor specific gene expression profiles: Applications in tumor biology, diagnosis and therapy | 0 | 0.00 | 0 | 0.00 | 0 | |
| 92 | 1 | 69 | 92 2003 LABORATORY INVESTIGATION 83(3):305-316
Bertucci F; Viens P; Tagett R; Nguyen C; Houlgatte R; Birnbaum D DNA arrays in clinical oncology: Promises and challenges | 0 | 0.00 | 1 | 0.50 | 0 | |
| 93 | 2 | 6 | 93 2003 LABORATORY MEDICINE 34(11):771-774
Woeste S Molecular profiling for cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 94 | 1 | 14 | 94 2003 LANCET 361(9369):1576-1577
Ramaswamy S; Perou CM DNA microarrays in breast cancer: the promise of personalised medicine | 0 | 0.00 | 3 | 1.50 | 0 | |
| 95 | 1 | 17 | 95 2003 LANCET 361(9369):1590-1596
Huang E; Cheng SH; Dressman H; Pittman J; Tsou MH; Horng CF; Bild A; Iversen ES; Liao M; Chen CM; West M; Nevins JR; Huang AT Gene expression predictors of breast cancer outcomes | 0 | 0.00 | 4 | 2.00 | 0 | |
| 96 | 1 | 85 | 96 2003 LANCET ONCOLOGY 4(3):177-185
Lonning PE Study of suboptimum treatment response: lessons from breast cancer | 0 | 0.00 | 2 | 1.00 | 0 | |
| 97 | 1 | 15 | 97 2003 LEUKEMIA 17(7):1324-1332
Staal FJT; van der Burg M; Wessels LFA; Barendregt BH; Baert MRM; van den Burg CMM; Van Huffel C; Langerak AW; van der Velden VHJ; Reinders MJT; van Dongen JJM DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers | 1 | 0.50 | 1 | 0.50 | 1 | |
| 98 | 1 | 22 | 98 2003 LEUKEMIA 17(7):1404-1410
Wallace J; Zhou Y; Usmani GN; Reardon M; Newburger P; Woda B; Pihan G BARCODE-ALL: accelerated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays | 0 | 0.00 | 0 | 0.00 | 0 | |
| 99 | 1 | 35 | 99 2003 LEUKEMIA 17(8):1557-1565
De Zen L; Bicciato S; Kronnie GT; Basso G Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification | 0 | 0.00 | 0 | 0.00 | 0 | |
| 100 | 1 | 52 | 100 2003 LEUKEMIA 17(9):1891-1900
Qiu J; Gunaratne P; Peterson LE; Khurana D; Walsham N; Loulseged H; Karni RJ; Roussel E; Gibbs RA; Margolin JF; Gingras MC Novel potential ALL low-risk markers revealed by gene expression profiling with new high-throughput SSH-CCS-PCR | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 101 | 1 | 8 | 101 2003 LEUKEMIA 17(11):2234-2237
Scrideli CA; Cazzaniga G; Fazio G; Pirola L; Callegaro A; Bassan R; Rambaldi A; Lo Nigro L; Basso G; Masera G; Biondi A Gene expression profile unravels significant differences between childhood and adult Ph plus acute lymphoblastic leukemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| 102 | 3 | 200 | 102 2003 LEUKEMIA 17(12):2358-2382
Larson RA; Daley GQ; Schiffer CA; Porcu P; Pui CH; Marie JP; Steelman LS; Bertrand FE; McCubrey JA Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002 | 0 | 0.00 | 0 | 0.00 | 0 | |
| 103 | 4 | 43 | 103 2003 LEUKEMIA 17(12):2454-2459
Bertrand FE; Spengeman JD; Shah N; LeBien TW B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression | 0 | 0.00 | 0 | 0.00 | 0 | |
| 104 | 2 | 48 | 104 2003 LEUKEMIA RESEARCH 27(9):765-774
Zent CS; Zhan FG; Schichman SA; Bumm KHW; Lin P; Chen JB; Shaughnessy JD The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype | 0 | 0.00 | 0 | 0.00 | 0 | |
| 105 | 2 | 41 | 105 2003 MAYO CLINIC PROCEEDINGS 78(9):1098-1109
Shaughnessy J Primer on medical genomics - Part IX: Scientific and clinical applications of DNA microarrays - Multiple myeloma as a disease model | 0 | 0.00 | 0 | 0.00 | 0 | |
| 106 | 1 | 36 | 106 2003 MOLECULAR AND CELLULAR BIOLOGY 23(1):186-194
Hsieh JJD; Ernst P; Erdjument-Bromage H; Tempst P; Korsmeyer SJ Proteolytic cleavage of MLL generates a complex of N-and C-terminal fragments that confers protein stability and subnuclear localization | 4 | 2.00 | 9 | 4.50 | 4 | |
| 107 | 1 | 35 | 107 2003 MOLECULAR CANCER THERAPEUTICS 2(7):671-677
Kees UR; Ford J; Watson M; Murch A; Ringner M; Walker RL; Meltzer P Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease | 0 | 0.00 | 0 | 0.00 | 0 | |
| 108 | 1 | 36 | 108 2003 MOLECULAR VISION 9(61-62):482-496
Rogojina A; Orr W; Song B; Geisert E Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines | 0 | 0.00 | 0 | 0.00 | 0 | |
| 109 | 1 | 37 | 109 2003 MONATSSCHRIFT KINDERHEILKUNDE 151(2):138-145
Schrappe M; Zimmermann M; Stanulla M; Schrauder A Stratification of ALL by using detection of minimal residual disease. Clinical use | 0 | 0.00 | 0 | 0.00 | 0 | |
| 110 | 2 | 29 | 110 2003 NATURE GENETICS 34(1):85-90
Cheok MH; Yang WL; Pui CH; Downing JR; Cheng C; Naeve CW; Relling MV; Evans WE Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells | 3 | 1.50 | 7 | 3.50 | 3 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 111 | 2 | 151 | 111 2003 NATURE REVIEWS CANCER 3(9):639-649
Greaves MF; Wiemels J Origins of chromosome translocations in childhood leukaemia | 1 | 0.50 | 2 | 1.00 | 1 | |
| 112 | 1 | 88 | 112 2003 NATURE REVIEWS CANCER 3(11):869-876
Liang P; Pardee AB Timeline - Analysing differential gene expression in cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 113 | 1 | 95 | 113 2003 NEW ENGLAND JOURNAL OF MEDICINE 348(6):538-549
Evans WE; McLeod HL Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects | 1 | 0.50 | 36 | 18.00 | 1 | |
| 114 | 2 | 40 | 114 2003 NEW ENGLAND JOURNAL OF MEDICINE 348(18):1777-1785
Staudt LM Molecular diagnosis of the hematologic cancers | 2 | 1.00 | 7 | 3.50 | 2 | |
| 115 | 1 | 38 | 115 2003 ONCOGENE 22(11):1629-1637
Zeisig BB; Garcia-Cuellar MP; Winkler TH; Slany RK The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell | 1 | 0.50 | 3 | 1.50 | 1 | |
| 116 | 1 | 73 | 116 2003 ONCOGENE 22(25):3952-3963
Nowicki MO; Pawlowski P; Fischer T; Hess G; Pawlowski T; Skorski T Chronic myelogenous leukemia molecular signature | 0 | 0.00 | 0 | 0.00 | 0 | |
| 117 | 1 | 59 | 117 2003 PATHOLOGIE BIOLOGIE 51(6):337-345
Dastugue N The interest of standard and molecular cytogenetics for diagnosis of acute leukemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| 118 | 2 | 27 | 118 2003 PHARMACOGENOMICS JOURNAL 3(5):257-260
Covitz PA Class struggle: expression profiling and categorizing cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 119 | 1 | 49 | 119 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(13):7853-7858
Rozovskaia T; Ravid-Amir O; Tillib S; Getz G; Feinstein E; Agrawal H; Nagler A; Rappaport EF; Issaeva I; Matsuo Y; Kees UR; Lapidot T; Lo Coco F; Foa R; Mazo A; Nakamura T; Croce CM; Cimino G; Domany E; Canaani E Expression profiles. of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements | 4 | 2.00 | 4 | 2.00 | 4 | |
| 120 | 1 | 9 | 120 2003 REVISTA CLINICA ESPANOLA 203(8):386-387
Morente MM; Piris MA The classification of the lymphomas: an advance of the cancer taxonomy in the 21st century | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 121 | 8 | 43 | 121 2003 SEMINARS IN HEMATOLOGY 40(4):268-273
Armstrong SA; Golub TR; Korsmeyer SJ MLL-rearranged leukemias: Insights from gene expression profiling | 0 | 0.00 | 0 | 0.00 | 0 | |
| 122 | 3 | 36 | 122 2003 SEMINARS IN HEMATOLOGY 40(4):274-280
Ferrando AA; Look AT Gene expression profiling in T-cell acute lymphoblastic leukemia | 0 | 0.00 | 0 | 0.00 | 0 | |
| 123 | 8 | 64 | 123 2003 SEMINARS IN HEMATOLOGY 40(4):281-295
Haferlach T; Kohlmann A; Kern W; Hiddemann W; Schnittger S; Schoch C Gene expression profiling as a tool for the diagnosis of acute leukemias | 0 | 0.00 | 0 | 0.00 | 0 | |
| 124 | 1 | 37 | 124 2003 TRENDS IN MOLECULAR MEDICINE 9(1):5-10
Hampton GM; Frierson HF Classifying human cancer by analysis of gene expression | 0 | 0.00 | 1 | 0.50 | 0 | |
| 125 | 4 | 32 | 125 2004 BLOOD 103(1):229-235
Poppe B; Vandesompele J; Schoch C; Lindvall C; Mrozek K; Bloomfield CD; Beverloo HB; Michaux L; Dastugue N; Herens C; Yigit N; De Paepe A; Hagemeijer A; Speleman F Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies | 0 | 0.00 | 0 | 0.00 | 0 | |
| 126 | 1 | 56 | 126 2004 BLOOD 103(1):291-300
Stankovic T; Hubank M; Cronin D; Stewart GS; Fletcher D; Bignell CR; Alvi AJ; Austen B; Weston VJ; Fegan C; Byrd PJ; Moss PAH; Taylor AMR Microarray analysis reveals that TP53-and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses | 0 | 0.00 | 0 | 0.00 | 0 | |
| 127 | 1 | 71 | 127 2004 GENE THERAPY 11(1):85-93
Bonamino M; Serafini M; D'Amico G; Gaipa G; Todisco E; Bernasconi S; Golay J; Biondi A; Introna M Functional transfer of CD40L gene in human B-cell precursor ALL blasts by second-generation SIN lentivectors | 0 | 0.00 | 0 | 0.00 | 0 | |
| 128 | 1 | 43 | 128 2004 JOURNAL OF BIOLOGICAL CHEMISTRY 279(2):825-830
Hug BA; Ahmed N; Robbins JA; Lazar MA A chromatin immunoprecipitation screen reveals protein kinase C beta as a direct RUNX1 target gene | 0 | 0.00 | 0 | 0.00 | 0 | |
| 129 | 3 | 28 | 129 2004 LEUKEMIA 18(1):63-71
Kohlmann A; Schoch C; Schnittger S; Dugas M; Hiddemann W; Kern W; Haferlach T Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients | 0 | 0.00 | 0 | 0.00 | 0 |
Generated by: HistCite(Vlad).
Version: 2004.01.07